Homozygous alpha-synuclein p.A53V in familial Parkinson's disease-Reference-Cited by-同舟云学术

Homozygous alpha-synuclein p.A53V in familial Parkinson's disease

Published:2017-09 Issue: Volume:57 Page:248.e7-248.e12
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Yoshino Hiroyo,Hirano Makito,Stoessl A. Jon,Imamichi Yoko,Ikeda Aya,Li Yuanzhe,Funayama Manabu,Yamada Ikuko,Nakamura Yusaku,Sossi Vesna,Farrer Matthew J.,Nishioka Kenya,Hattori Nobutaka

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference28 articles.

1. A broken alpha -helix in folded alpha -Synuclein;Chandra;J. Biol. Chem.,2003

2. KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity;Dettmer;Proc. Natl. Acad. Sci. U. S. A.,2015

3. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein;Giasson;Neuron,2002

4. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease;Gibb;J. Neurol. Neurosurg. Psychiatry,1988

5. 100 years of Lewy pathology;Goedert;Nat. Rev. Neurol.,2013

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RXR nuclear receptor signaling modulates lipid metabolism and triggers lysosomal clearance of alpha-synuclein in neuronal models of synucleinopathy;Cellular and Molecular Life Sciences;2024-08-20

2. Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways;Proceedings of the National Academy of Sciences;2024-08-12

3. The First East Asian Patient With Parkinson’s Disease Caused by the A53E SNCA Mutation With Early Progression to Dementia;Journal of Movement Disorders;2024-07-31

4. Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophy;2024-07-09

5. Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis;Movement Disorders;2024-06-30